BDH Industries

Mumbai, India Founded: 1935 • Age: 91 yrs Listed

Therapeutic pharmaceutical formulations are manufactured in Mumbai.

Page last updated 18 Aug 2026

About BDH Industries

BDH Industries is a publicly listed company based in Mumbai (India) founded in 1935. Therapeutic pharmaceutical formulations are manufactured in Mumbai. The company has 112 employees. Its Indian entity Bdh Industries Limited reported revenue of ₹98.19 Cr. BDH Industries offers products and services including Industrial Chemicals and Equipment Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

BDH Industries was founded in 1935 and operates in the pharmaceuticals sector, with a focus on producing oral solid dosage technologies, formulations, specialty formulations, and bulk drugs. Products are provided across therapeutic areas including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antimalarial, anti-inflammatory, cardiovascular, dermatological, NSAIDs, psychotropic, trichology, vitamins, and minerals. The manufacturing plant is situated in Mumbai, India.

Headquarters Mumbai, India
Employees 112
Stage Public
Sectors
Healthcare
Website bdhind.com
Legal Name Bdh Industries Limited

Operational Areas

Healthcare → Traditional Health & Nutrition

Key Metrics

Market Cap
₹234 Cr
BDH · BSE
Share Price
₹412.00
+1.25% today
Revenue
₹95.95 Cr
FY 2025-26 · +44.3% YoY
EBITDA
₹13.87 Cr
Margin 14.5%
Net Profit
₹10.80 Cr
FY 2025-26 · +16.3% YoY
P/E (TTM)
20.5x
P/B 3.2x
ROE
15.1%
ROCE 20.8%
Debt / Equity
0.02
Interest cover 0.5x
Employee Count
112

Associated legal entities of BDH Industries

BDH Industries operates through Bdh Industries Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Bdh Industries Limited Listed CIN L24100MH1990PLC059299	Active	05 Dec 1990	Mumbai, Maharashtra	₹98.2 Cr	96	8	View details

Products & Services of BDH Industries

BDH Industries offers a comprehensive portfolio of products and services, including Industrial Chemicals and Equipment Services.

Industrial Chemicals

Manufacturing Products

Industrial chemicals are produced and supplied for various uses in the sector

Equipment Services

Services

Equipment maintenance services are offered to support industrial operations

Board of directors of Bdh Industries Limited (BDH Industries)

Bdh Industries Limited is the primary company behind BDH Industries. The board of Bdh Industries Limited currently have 6 directors; the longest-serving is Karthika Nair, appointed in 1999. 7 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Karthika Nair DIN 00019695	Director	27 Oct 1999	27 yrs	Bdh Industries Limited
Jayashree Gopakumar Nair DIN 00027467	Managing Director	01 Apr 2009	17 yrs 7 mo	Bdh Industries Limited
Suresh Chandra Kachhara DIN 00019666	Managing Director	01 Apr 2009	17 yrs 7 mo	Bdh Industries Limited
Prabhakar Ramchandra Dalal DIN 00544948	Director	01 Apr 2024	2 yrs 7 mo	Bdh Industries Limited
Mitul Manubhai Patel DIN 10413137	Director	01 Apr 2024	2 yrs 7 mo	Bdh Industries Limited
Suresh Chandra Kookada DIN 01738594	Director	01 Apr 2024	2 yrs 7 mo	Bdh Industries Limited

People of BDH Industries

2 people are tracked at BDH Industries (2 in leadership); the tracked headcount is 112.

Name	Role	Group
Suresh Chandra Kachhara	Managing Director & CFO	Leadership
Jayashree Nair	Chairperson & Managing Director	Leadership

Premium access

Complete people profiles for BDH Industries

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

Full employee list
Team structure
Board tenure
Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of BDH Industries

BDH Industries is a publicly listed company on the BSE with ticker symbol BDH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

IPO date24 Apr 1995
Listed onBSE: 524828
Listed entityBDH Industries Limited
Exchange sectorHealth technology
ISININE278D01018
Share price₹458.25 (+4.74% on the day) · 2026-10-14
Market capitalisation₹252 Cr
Price to earnings22.5
EPS (diluted, trailing year)₹20.34
Dividend yield1.14%
Volume (last session)2,368

Financials of BDH Industries

Exchange-reported figures of Bdh Industries Limited, the listed company behind BDH Industries (BSE: BDH).

Financial Highlights

FY 2025-26 · Standalone

Revenue

₹95.95 Cr

+44.3% YoY

EBITDA

₹13.87 Cr

+19.4% YoY

Profit After Tax

₹10.80 Cr

+16.3% YoY

Net Worth

₹77.02 Cr

+12.0% YoY

Total Assets

₹79.22 Cr

+13.3% YoY

Total Debt

₹2.02 Cr

+106.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	95.95	66.51	85.83	74.46	69.39	57.45	59.48
Revenue growth	+44.3%	-22.5%	+15.3%	+7.3%	+20.8%	-3.4%	-
EBITDA	13.87	11.62	12.44	10.94	9.07	8.51	8.98
EBITDA margin	+14.5%	+17.5%	+14.5%	+14.7%	+13.1%	+14.8%	+15.1%
Profit before tax	15.18	12.48	13.27	11.05	9.54	8.74	8.13
Net profit	10.80	9.29	9.89	8.19	6.87	6.35	5.96
Net profit margin	+11.3%	+14.0%	+11.5%	+11.0%	+9.9%	+11.1%	+10.0%
EPS (₹)	18.78	16.11	17.14	14.25	12.55	10.71	10.01
Balance sheet
Total assets	79.22	69.94	71.01	60.23	51.53	52.42	48.16
Net worth	77.02	68.76	62.16	54.70	48.59	43.07	38.24
Total debt	2.02	0.98	8.69	4.85	2.25	8.51	9.22
Cash & bank	29.35	31.16	25.14	25.96	18.82	22.62	22.99
Net working capital	61.85	50.81	50.60	40.71	31.77	32.10	27.11
Cash flow
Cash from operations	(2.41)	14.77	(1.87)	6.29	3.02	0.78	11.35
Cash from investing	2.22	1.62	(0.31)	0.49	1.38	1.29	0.74
Cash from financing	(1.61)	(10.37)	1.36	0.37	(8.21)	(2.44)	(6.37)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	22.38	29.03	29.34	18.96	18.62	17.82	16.20	16.23
Revenue growth (YoY)	+20.2%	+62.9%	+81.1%	+16.8%	+14.5%	-	-	-
Other income	0.45	0.61	0.53	0.55	0.55	0.57	0.46	0.43
Total expenses	18.91	24.83	25.11	15.63	16.51	14.76	12.67	13.18
EBITDA	3.47	4.20	4.23	3.33	2.11	3.06	3.53	3.05
EBITDA margin	+15.5%	+14.5%	+14.4%	+17.6%	+11.3%	+17.2%	+21.8%	+18.8%
Depreciation	0.21	0.22	0.22	0.22	0.22	0.23	0.23	0.23
Interest	0.01	0.01	0.01	0.03	0.01	0.01	0.01	0.04
Profit before tax	3.70	4.58	4.53	3.63	2.43	3.39	3.75	3.21
Tax	0.97	1.71	1.04	1.01	0.61	0.91	0.94	0.81

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 03 Nov 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	22.38	29.03	29.34	18.96	18.62	17.82	16.20	16.23
Revenue growth (YoY)	+20.2%	+62.9%	+81.1%	+16.8%	+14.5%	-	-	-
Other income	0.45	0.61	0.53	0.55	0.55	0.57	0.46	0.43
Total expenses	18.91	24.83	25.11	15.63	16.51	14.76	12.67	13.18
EBITDA	3.47	4.20	4.23	3.33	2.11	3.06	3.53	3.05
EBITDA margin	+15.5%	+14.5%	+14.4%	+17.6%	+11.3%	+17.2%	+21.8%	+18.8%
Depreciation	0.21	0.22	0.22	0.22	0.22	0.23	0.23	0.23
Interest	0.01	0.01	0.01	0.03	0.01	0.01	0.01	0.04
Profit before tax	3.70	4.58	4.53	3.63	2.43	3.39	3.75	3.21
Tax	0.97	1.71	1.04	1.01	0.61	0.91	0.94	0.81

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	95.95	66.51	85.83	74.46	69.39	57.45	59.48
Revenue growth	+44.3%	-22.5%	+15.3%	+7.3%	+20.8%	-3.4%	-
Other income	2.24	1.84	1.58	0.84	1.33	1.30	0.80
Total expenses	82.08	54.89	73.39	63.52	60.32	48.94	50.50
Employee cost	7.55	7.44	7.43	6.96	6.62	6.26	7.50
EBITDA	13.87	11.62	12.44	10.94	9.07	8.51	8.98
EBITDA margin	+14.5%	+17.5%	+14.5%	+14.7%	+13.1%	+14.8%	+15.1%
Depreciation	0.87	0.91	0.57	0.57	0.63	0.79	0.96
Interest	0.06	0.07	0.18	0.16	0.23	0.28	0.69
Profit before tax	15.18	12.48	13.27	11.05	9.54	8.74	8.13
Tax	4.38	3.19	3.38	2.86	2.33	2.39	2.17
Net profit	10.80	9.29	9.89	8.19	6.87	6.35	5.96
Net profit margin	+11.3%	+14.0%	+11.5%	+11.0%	+9.9%	+11.1%	+10.0%
EPS (₹)	18.78	16.11	17.14	14.25	12.55	10.71	10.01

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	5.76	5.76	5.76	5.76	5.76	5.94	5.94
Reserves & surplus	71.26	63.00	56.40	48.94	42.83	37.13	32.30
Shareholders' funds (net worth)	77.02	68.76	62.16	54.70	48.59	43.07	38.24
Secured loans	2.02	0.98	8.69	4.85	2.25	8.51	9.22
Unsecured loans	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total debt	2.02	0.98	8.69	4.85	2.25	8.51	9.22
Total liabilities	79.22	69.94	71.01	60.23	51.53	52.42	48.16
Assets
Gross block	38.07	38.04	37.83	35.94	35.93	35.98	35.97
Net block	18.82	19.66	20.35	19.04	19.61	20.30	21.10
Capital work in progress	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.35	0.35	0.35	0.35	0.00	0.00	0.00
Inventories	5.37	7.39	5.00	7.16	6.71	5.43	5.01
Sundry debtors	31.61	14.18	28.36	16.64	14.52	15.18	11.02
Cash & bank balances	29.35	31.16	25.14	25.96	18.82	22.62	22.99
Loans & advances	13.46	14.02	14.07	10.71	9.05	7.31	4.94
Total current assets	79.79	66.75	72.57	60.47	49.10	50.54	43.96
Total current liabilities	17.94	15.94	21.97	19.76	17.33	18.44	16.85
Net working capital	61.85	50.81	50.60	40.71	31.77	32.10	27.11
Total assets	79.22	69.94	71.01	60.23	51.53	52.42	48.16

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	31.16	25.14	25.96	18.82	22.62	22.99	17.27
Net cash from operating activities	(2.41)	14.77	(1.87)	6.29	3.02	0.78	11.35
Net cash from investing activities	2.22	1.62	(0.31)	0.49	1.38	1.29	0.74
Net cash from financing activities	(1.61)	(10.37)	1.36	0.37	(8.21)	(2.44)	(6.37)
Net change in cash	(1.81)	6.02	(0.82)	7.15	(3.81)	(0.37)	5.72
Closing cash	29.35	31.16	25.14	25.96	18.82	22.62	22.99

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+44.3%	-22.5%	+15.3%	+7.3%	+20.8%	-3.4%	-
EBITDA growth	+19.4%	-6.6%	+13.7%	+20.6%	+6.6%	-5.2%	-
PBT growth	+21.6%	-6.0%	+20.1%	+15.8%	+9.2%	+7.5%	+24.3%
Net income growth	+16.3%	-6.1%	+20.8%	+19.2%	+8.2%	+6.5%	-
Revenue CAGR (3Y)	+8.8%	-1.4%	+14.3%	+7.8%	+10.3%	+11.9%	+10.9%
EBITDA CAGR (3Y)	+8.2%	+8.6%	+13.5%	+6.8%	+9.0%	+16.6%	+23.4%
Profitability & leverage
Net income margin	+11.3%	+14.0%	+11.5%	+11.0%	+10.4%	+11.1%	+10.0%
Return on capital employed	+20.8%	+18.1%	+20.9%	+20.6%	+19.3%	+18.5%	+18.9%
Return on net worth	+15.1%	+14.5%	+17.3%	+16.3%	+16.2%	+16.2%	+17.0%
Debt / equity	0.02	0.08	0.12	0.07	0.12	0.23	0.32
Long-term debt / equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest cover	0.46	0.65	1.52	1.54	2.73	3.63	8.60
Efficiency & per share
Fixed asset turnover	2.61	1.82	2.41	2.15	2.00	1.66	1.72
Inventory turnover	15.04	10.74	14.12	10.74	11.43	11.01	9.35
Debtors turnover	4.19	3.13	3.81	4.78	4.67	4.39	5.04
EPS (₹)	18.78	16.11	17.14	14.25	12.55	10.71	10.01
Dividend per share (₹)	5.00	4.50	4.50	4.00	3.60	3.00	2.50
Book value per share (₹)	131.47	117.14	105.67	92.71	82.07	70.24	62.09

Web traffic of BDH Industries

The website of BDH Industries (bdhind.com) receives about 1.5K visits a month.

Monthly visits
1.5K
▼ 11.6% vs previous month

Similar websites

Websites whose visitors overlap most with BDH Industries. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
DCM Shriram Industries	dcmsr.com	60%	6.5K	#2,706,559	View details

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as BDH Industries (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Inventia Healthcare	Oral solid drug delivery systems are manufactured and developed.	1985	Mumbai, Maharashtra, India	USD 42.49 M	USD 89.42 M	962
Strides Pharma Science	Generic, semi-solid, and liquid dosage forms are manufactured.	1990	Bengaluru, Karnataka, India		USD 508.93 M	5,180
Sun Pharma	Specialty generic pharmaceuticals and APIs are manufactured and marketed.	1983	Mumbai, Maharashtra, India		USD 6.21 B	25,870

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bdh Industries

BDH Industries standalone net profit rises 48.63% in the June 2026 quarter | Capital Market News - Business Standard

Business Standard • 2 months ago

Q1 Results 14th Aug Live: Anupam Rasayan PAT up marginally, Ashok Leyland, NMDC, Alkem Lab, Bharat Dynamics, Voltas, 3M India, Cochin Shipyard, Physicswallah, Cholamandalam Fin, PTC Ind, Natco Pharma, Borosil to announce Q1 results, TMPV, Max Health lead Nifty 50 losers after Q1, Page Ind, Jubilant, LG Electronics, Honasa shares zoom - The HinduBusinessLine

Thehindubusinessline • 2 months ago

Q1 Results 14th Aug Highlights: BDL, Ashok Leyland, 3M India Q1 PAT rise y-o-y, Electrotherm, NATCO Pharma, Alkem Lab PAT decline, NMDC, Voltas, Cochin Shipyard, Physicswallah, PTC Ind, Borosil to announce Q1 results - The HinduBusinessLine

Thehindubusinessline • 2 months ago

BDH Industries standalone net profit declines 15.88% in the March 2025 quarter | Capital Market News - Business Standard

Business Standard • 1 year ago

BDH Industries Recommended Dividend Of 4 Rupees Per Share

Reuters • 3 years ago

Premium access

Complete news archive for BDH Industries

Full article history, source details, and older brand coverage require an active premium plan.

Full article archive
Source and publication date
Older coverage
Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BDH Industries

When was BDH Industries founded?

BDH Industries was founded in 1935.

Where is BDH Industries located?

BDH Industries is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

How many employees does BDH Industries have?

BDH Industries has 112 employees.

What is the annual revenue of BDH Industries?

The primary company behind BDH Industries, Bdh Industries Limited, reported revenue of ₹98.19 Cr for FY 2026, up 44% year on year.

What does BDH Industries do?

What products or services does BDH Industries offer?

BDH Industries offers Industrial Chemicals and Equipment Services.

Is BDH Industries publicly traded?

Yes, BDH Industries is publicly traded on BSE under the ticker symbol BDH.

Which legal entities are associated with BDH Industries?

BDH Industries operates through Bdh Industries Limited.

Who are the directors of BDH Industries?

The legal entities of BDH Industries currently have 7 directors, including Jayashree Gopakumar Nair, Karthika Nair, Suresh Chandra Kachhara and others.